← Eichor
Study identifier: NCT05843500 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Chronic Thromboembolic Disease Registry

Condition: Chronic Thromboembolic Pulmonary Hypertension · Chronic Thromboembolic Disease  ·  Sponsor: University of California, San Francisco

PhaseN/A
Planned participants100
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

The goal of this patient registry is to learn about the natural history in patients with chronic thromboembolic disease (CTD) and/or chronic thromboembolic pulmonary hypertension (CTEPH). The main question\[s\] it aims to answer are: * Long-term outcome after various types of treatment, including medication, balloon pulmonary angioplasty, and pulmonary endarterectomy * Effect of treatment on patient's quality of life and exercise tolerance Participants will be followed longitudinally to assess their health outcomes and quality of life via chart review and health quality surveys.

This description comes directly from the study's public registry record.

Talk to the study team

Miles Conrad, MD  ·  (415) 353-1300  ·  miles.conrad@ucsf.edu

Xiao Wu, MD  ·  628-286-7340  ·  xiao.wu@ucsf.edu

Always discuss trial participation with your own doctor first.

Locations (1)

University of California San FranciscoSan Francisco, California, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05843500